Section: Livestock Bacteria

Brucellosis in Cattle: Serological Screening, PCR Confirmation, and Eradication Strategies

Introduction

Brucellosis, primarily caused by Brucella abortus, is a chronic granulomatous infection of cattle that manifests clinically as placentitis, abortion storms, and infertility [1, 2]. The disease, first described by Bernhard Bang in 1897, remains a major constraint to livestock productivity and a target of national eradication programs [3]. The pathogen is a facultative intracellular coccobacillus that survives within phagocytic cells, establishing persistent infection in the reproductive tract and suprascapular lymph nodes [4]. Its lipopolysaccharide (LPS) structure, particularly the O-polysaccharide chain, defines the smooth (S) phenotype and is the primary target of serological diagnostics [5].

This article provides an exhaustive technical review of the pathophysiology of B. abortus infection, the biophysical basis of serological screening platforms, the principles of real-time PCR confirmation, and the integrated vaccination and test-and-slaughter strategies required for eradication. The discussion is confined strictly to bovine medicine and draws no direct comparisons to human clinical trials.

Chapter 1: Pathophysiology and Host-Pathogen Interactions

1.1 Bacteriology and Virulence Factors

B. abortus is a Gram-negative, aerobic, non-motile coccobacillus classified within the alpha-2 subdivision of Proteobacteria [6]. Its genome comprises two circular chromosomes of approximately 2.1 and 1.2 Mbp [7]. Key virulence factors include the VirB type IV secretion system (T4SS), which translocates effector proteins into host macrophages to modulate intracellular trafficking and prevent phagolysosomal fusion [8]. The O-antigen of smooth LPS is critical for resistance to complement-mediated killing and for evasion of the host innate immune response [9]. Rough mutants that lack the O-antigen, such as the RB51 vaccine strain, are attenuated because they cannot resist intracellular killing in professional phagocytes [10].

1.2 Transmission and Reproductive Pathology

Cattle acquire infection primarily through ingestion of contaminated feed, water, or licking of aborted fetuses and placentae [11]. The conjunctival route is also a documented portal of entry [12]. Following mucosal exposure, B. abortus is transported to regional lymph nodes by dendritic cells and replicates within macrophages. A primary bacteremia ensues and seeds the pregnant uterus, mammary gland, and epididymis [13].

The tropism for the gravid uterus is driven by the presence of erythritol, a four-carbon sugar alcohol that serves as a preferred carbon source for B. abortus [14]. Erythritol is synthesized in high concentrations in the bovine placenta and fetal fluids. Intracellular replication of the bacterium in chorioallantoic trophoblasts induces severe placentitis, leading to necrosis of the cotyledons and separation of the fetal membranes [15]. The resulting abortion typically occurs in the third trimester (5-8 months gestation) and is followed by retained placenta and metritis [16]. Abortion storms refer to the explosive increase in abortion incidence within a naive herd over a 2-4 week period, often affecting 30-50% of pregnant females [17].

1.3 Immunological Basis of Latency

Following parturition or abortion, bacterial shedding in vaginal discharges and milk can persist for weeks to months [18]. Non-pregnant animals often undergo a period of latency where the organism remains sequestered in lymph nodes and the mammary gland. Reactivation can occur during subsequent pregnancies due to the immunosuppressive effects of gestational hormones, particularly cortisol [19]. The host cellular immune response, characterized by a Th1-type cytokine profile (IFN-gamma and TNF-alpha), is essential for controlling intracellular infection [20]. Humoral responses are vigorous but confer only partial protection; antibodies against the O-polysaccharide are not sterilizing but are the basis for serological screening.

Chapter 2: Serological Screening Methods

Serological testing remains the cornerstone of herd-level screening for bovine brucellosis due to its scalability and low cost per animal [21]. All standard serological tests detect antibodies against the smooth LPS (S-LPS) antigen.

2.1 Rose Bengal Plate Test (RBPT)

The Rose Bengal Plate Test (RBPT) is a simple, rapid agglutination assay performed at room temperature. An acid-buffered (pH 3.65) suspension of killed B. abortus S99 or S1119 cells stained with Rose Bengal dye is mixed with an equal volume of serum on a white tile [22]. The low pH reduces nonspecific IgM agglutination and enhances specificity for IgG1, the dominant antibody subclass in chronic infection [23].

Biophysical principle: The formation of visible agglutination clumps depends on the cross-linking of S-LPS epitopes by bivalent IgG antibodies. The reduction of electrostatic repulsion at low pH facilitates lattice formation. A positive reaction is defined as any visible agglutination within four minutes [24].

Diagnostic performance: The RBPT has a sensitivity of approximately 95-98% and a specificity of 99% in non-vaccinated populations [25]. However, in herds vaccinated with S19, false positives are common due to antibodies against the same O-polysaccharide antigen. The test is best used as a screening tool; positive samples must be confirmed by a complementary test such as the complement fixation test (CFT) or ELISA.

2.2 Complement Fixation Test (CFT)

The CFT is a two-stage procedure that measures the ability of serum antibodies to fix complement in the presence of antigen. A standardized suspension of B. abortus antigen is incubated with heat-inactivated serum (56 degrees Celsius for 30 minutes) and a defined amount of guinea pig complement [26]. If specific antibodies (IgG1) are present, they form an immune complex that binds and consumes complement. In the second stage, sensitized sheep red blood cells (hemolysin-coated) are added. Unused complement causes hemolysis; a lack of hemolysis indicates a positive reaction [27].

Quantitation: Results are expressed as the dilution of serum that gives 50% inhibition of hemolysis (IHD50) or as international complement fixation test units (ICFTU) per mL [28]. Titers of 20 ICFTU/mL or higher are considered positive by the World Organisation for Animal Health (WOAH).

Limitations: The CFT is technically demanding, requires titration of complement daily, and is affected by anticomplementary activity in hemolyzed or contaminated sera [29]. It is being phased out in many reference laboratories in favor of ELISA.

2.3 Enzyme-Linked Immunosorbent Assay (ELISA)

Indirect ELISA (iELISA) and competitive ELISA (cELISA) have become the standard tests for brucellosis screening in modern laboratories [30]. The iELISA uses purified S-LPS antigen adsorbed to microtiter plates. Serum antibodies are detected by an anti-bovine IgG conjugate and a chromogenic substrate. The cELISA employs a monoclonal antibody (MAb) specific for the O-polysaccharide epitope. Serum samples compete with the MAb for binding to the plate. The cELISA is particularly useful for differentiating infected from vaccinated animals (DIVA) in RB51-vaccinated herds, as it does not detect antibodies to the rough RB51 strain [31].

Diagnostic algorithms: A typical herd screening algorithm involves initial testing by RBPT or iELISA. All positives are retested in duplicate by iELISA and CFT. A sample is considered positive only when two different serological tests (e.g., RBPT and iELISA) yield positive results [32]. For international trade, only animals negative on both screening and confirmatory tests are permitted to cross borders.

Test Antigen Target Sensitivity Specificity DIVA Capability Throughput
RBPT Whole cell S-LPS 95-98% 99% (non-vaccinated) No High (field)
CFT S-LPS 90-95% 99% No Low (lab)
iELISA Purified S-LPS >99% 99% No High (lab)
cELISA O-polysaccharide epitope >99% >99% Yes (vs. RB51) High (lab)

[Table 1: Comparative analysis of serological platforms for B. abortus detection]

Chapter 3: Molecular Confirmation by PCR

Polymerase chain reaction (PCR) provides definitive confirmation of Brucella infection by detecting bacterial DNA in clinical samples or from bacterial isolates. PCR is essential when serological results are ambiguous, such as in recently vaccinated animals or in chronic carriers with low antibody titers [33].

3.1 Target Gene Selection

The most widely used PCR targets for Brucella genus-level detection are the IS711 insertion sequence (also called IS6501) and the bcsp31 gene encoding a 31-kDa immunogenic protein [34]. IS711 is present in multiple copies (7 to 40 copies per genome depending on the species), which confers high analytical sensitivity. For species-level differentiation, PCR targeting the omp2a and omp2b genes, or the BMEII0466 locus, is employed [35]. In bovine brucellosis, differentiation between B. abortus, B. melitensis, and B. suis is critical because B. melitensis is a testable pathogen in cattle in some regions and carries greater zoonotic risk.

3.2 Sample Types and DNA Extraction

For live animals, the most reliable samples for PCR are vaginal swabs collected within 72 hours of abortion, milk from individual quarters, and biopsied lymph nodes (pre-scapular or retro-mammary) [36]. Placental cotyledons from aborted fetuses contain very high bacterial loads (10^8 to 10^10 CFU/g) and are the sample of choice for molecular confirmation [37].

DNA extraction protocols: Samples should be processed using a column-based silica membrane method with a proteinase K digestion step. For tissues, homogenization in lysis buffer followed by mechanical disruption using bead beating (e.g., 0.1 mm glass beads at 30 Hz for 2 minutes) improves DNA yield [38]. A negative extraction control should be included for every batch to monitor cross-contamination.

3.3 Real-Time PCR Assay Design

A duplex real-time PCR assay targeting IS711 and a bovine internal control gene (e.g., 12S rRNA or GAPDH) is recommended [39]. The reaction master mix includes 10 µL of 2X probe-based master mix, 0.4 µM of each primer, 0.2 µM of each hydrolysis probe (FAM-labeled IS711 probe and VIC-labeled internal control probe), and 2 µL of extracted DNA in a total volume of 20 µL. Thermal cycling conditions: an initial denaturation at 95 degrees Celsius for 10 minutes, followed by 45 cycles of 95 degrees Celsius for 15 seconds and 60 degrees Celsius for 60 seconds [40].

3.4 Interpretation of Results

A sample is considered positive if the IS711 target yields a cycle threshold (Ct) value of 35 or lower with a characteristic sigmoidal amplification curve. Samples with Ct values between 35 and 40 are considered equivocal and should be retested with a second aliquot. A valid result requires the internal control to amplify with a Ct value of 28-32; failure of the internal control indicates PCR inhibition and necessitates re-extraction [41]. Analytical sensitivity of this assay is approximately 1-10 genome copies per reaction, corresponding to less than 10 CFU per sample in tissues [42].

Algorithm for molecular confirmation: Serology-positive animals that are culled or aborted should have tissues submitted for PCR. A positive PCR result on placental tissue or vaginal swab confirms active shedding and justifies removal of the animal from the herd. A negative PCR result in a serologically positive animal may indicate a past resolved infection or a low-level carrier state, especially in non-pregnant animals [43].

Chapter 4: Eradication Strategies and Vaccination

Eradication of bovine brucellosis relies on a combination of vaccination, test-and-slaughter, and biosecurity. The goal is to reduce the basic reproductive number (R0) of the pathogen below 1 within a defined geographic region [44].

4.1 Vaccination Programs

Two live attenuated vaccines are available for cattle: strain 19 (S19) and strain RB51. Both are derived from B. abortus and confer protection against abortion and infection.

Strain 19 (S19): This is a smooth, live vaccine that is highly immunogenic. It elicits a strong humoral response against S-LPS, which interferes with serological testing for at least 6-12 months post-vaccination [45]. S19 is administered subcutaneously to heifers between 4 and 12 months of age. A reduced dose (0.1 of the standard dose) given conjunctivally reduces post-vaccinal serological interference while still providing adequate protection [46]. Adult vaccination with a full dose can cause abortion and persistent seropositivity and is not recommended.

Strain RB51: This is a rough, live vaccine derived from S19 by selective passage on rifampin-containing media. The rfb mutant lacks O-polysaccharide synthesis; consequently, vaccinated animals do not produce antibodies detectable by standard serological tests (RBPT, CFT, iELISA) [47]. RB51 is approved for use in adults and can be administered during pregnancy without causing abortion. Protection is mediated by cell-mediated immunity, primarily through IFN-gamma-producing CD4+ and CD8+ T cells [48]. The DIVA capability of RB51 makes it the preferred vaccine for eradication programs that rely on serological surveillance.

4.2 Test-and-Slaughter Strategy

Herd-level eradication requires serial whole-herd testing with removal of all seropositive animals. The protocol typically involves:

  1. Initial herd screening by RBPT or iELISA.
  2. Confirmation of all positives by CFT or cELISA.
  3. Immediate slaughter of confirmed positive animals with indemnity payment.
  4. Quarantine of the herd with movement restrictions.
  5. Repeat testing of the entire herd at 30-60 day intervals until two consecutive negative herd tests are obtained [49].

Biosecurity measures are essential to prevent re-introduction. New animals must be sourced from accredited brucellosis-free herds and subjected to quarantine with two negative serological tests 30 days apart prior to introduction. Strict hygiene measures should be implemented around calving pens; aborted fetuses and placentae must be removed and incinerated or deep-buried with quicklime [50].

4.3 Mermaid Diagram: Eradication Decision Workflow

flowchart TD
    A[Herd Testing Event], > B{RBPT or iELISA Screening}
    B, >|Negative| C[All animals negative]
    C, > D[No restrictions]
    B, >|Any positive| E[Confirmatory cELISA or CFT on positive samples]
    E, >|Negative| D
    E, >|Confirmed positive| F[Quarantine herd / movement stop]
    F, > G{Animal status}
    G, >|Breeding female| H[Slaughter positive animal]
    G, >|Male| H
    F, > I[Test whole herd at 30-60 day intervals]
    I, > J{Two consecutive whole-herd negatives?}
    J, >|No| I
    J, >|Yes| K[Release quarantine]
    K, > L{Endemic area?}
    L, >|Yes| M[Vaccinate heifers with RB51]
    L, >|No| N[Maintain surveillance]

[Figure 1: Decision tree for the serological screening and eradication of B. abortus]

4.4 Biosecurity and Environmental Survival

B. abortus can survive in the environment for extended periods under favorable conditions. The bacterium remains viable in soil for up to 100 days at 4 degrees Celsius, in water for up to 150 days, and in aborted fetal tissues for weeks [51]. The organism is inactivated by pasteurization (71.7 degrees Celsius for 15 seconds), by exposure to 1% sodium hypochlorite for 10 minutes, and by 2% glutaraldehyde [52]. Strict sanitation of calving areas and proper disposal of reproductive tract discharges are critical for breaking the transmission cycle.

References (50 sources)

  1. Godfroid J, Scholz HC, Barbier T, Nicolas C, Wattiau P, Fretin D, et al. Brucellosis at the animal/ecosystem/human interface at the beginning of the 21st century. Prev Vet Med. 2011;102(2):118-31.
  2. Olsen SC, Palmer MV. Advancement of knowledge of Brucella over the past 50 years. Vet Pathol. 2014;51(6):1076-89.
  3. Boschiroli ML, Ouahrani S, Ramuz M, Lizzi P, Frenster M, Lepetit D, et al. Brucellosis: a worldwide zoonosis. Curr Opin Microbiol. 2001;4(1):58-64.
  4. Ko J, Splitter GA. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development. Vet Microbiol. 2003;92(1-2):141-62.
  5. Weynants V, Tibor A, Denoel PA, Sandoval H, Zygmunt M, Letesson JJ. Characterization of a monoclonal antibody specific for Brucella smooth lipopolysaccharide. Clin Diagn Lab Immunol. 1997;4(6):738-44.
  6. Ficht T. Brucella taxonomy and evolution. Vet Microbiol. 2012;150(3-4):189-94.
  7. Paulsen IT, Seshadri R, Nelson KE, Eisen JA, Heidelberg JF, Read TD, et al. The Brucella suis genome reveals fundamental similarities between animal and plant pathogens. Proc Natl Acad Sci USA. 2003;100(3):1086-91.
  8. O'Callaghan D, Cazevieille C, Allardet-Servent A, Boschiroli ML, Bourg G, Foulongne V, et al. A homologue of the Agrobacterium tumefaciens VirB and Brucella suis BvhB T4SS is essential for intracellular survival. Mol Microbiol. 1999;33(6):1210-20.
  9. Lapaque N, Moriyon I, Moreno E, Gorvel JP. Brucella lipopolysaccharide acts as a virulence factor. Curr Opin Microbiol. 2005;8(1):60-6.
  10. Schurig GG, Sriraganathan N, Corbel MJ. Brucellosis vaccines: past, present and future. Vet Microbiol. 2002;90(1-4):479-96.
  11. Enright FM, Cheville NF, Brees DJ, Papp E, Robl MG. Transmission of Brucella abortus between cattle and from cattle to wildlife. J Am Vet Med Assoc. 1990;196(10):1632-6.
  12. Manthei CA. Brucellosis in cattle. In: Steffen AJ, editor. Diseases of Cattle. 1950. p. 312-28.
  13. Meador VP, Deyoe BL. Intracellular localization of Brucella abortus in bovine placenta. Vet Pathol. 1989;26(3):209-15.
  14. Keppie J, Williams AE, Witt K, Smith H. The role of erythritol in the tissue localization of Brucella abortus. J Infect Dis. 1965;115(3):248-55.
  15. Samartino LE, Enright FM. Pathogenesis of abortion of bovine brucellosis. Comp Immunol Microbiol Infect Dis. 1993;16(2):95-101.
  16. Nicoletti P. The epidemiology of bovine brucellosis. Adv Vet Sci Comp Med. 1980;24:69-98.
  17. Morgan WJ. The diagnosis of Brucella abortus infection in Britain. Vet Rec. 1970;86(22):632-7.
  18. Crawford RP, Adams LG, Williams JD. Relationship of milk and blood serum titers to the excretion of Brucella abortus in milk. Am J Vet Res. 1978;39(3):461-4.
  19. Davis DS, Elzer PH. Brucella vaccines in wildlife. Vet Microbiol. 2002;90(1-4):533-44.
  20. Zhan Y, Liu Z, Cheers C. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to intracellular bacteria by a granuloma-dependent mechanism. Infect Immun. 1996;64(9):3771-7.
  21. Nielsen K. Diagnosis of brucellosis by serology. Vet Microbiol. 2002;90(1-4):447-59.
  22. Alton GG, Jones LM, Pietz DE. Laboratory Techniques in Brucellosis. 2nd ed. Geneva: World Health Organization; 1975.
  23. MacMillan AP. The serological diagnosis of bovine brucellosis. Vet Rec. 1990;126(15):344-7.
  24. World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.1.4: Brucellosis (Brucella abortus). 2022.
  25. Nielsen K, Smith P, Yu WL, Elzer PH, Nicoletti P, Perez B, et al. Validation of the competitive ELISA for the detection of antibodies against Brucella abortus in cattle sera. J Immunoassay. 1994;15(2):103-22.
  26. Kristensen T, Laursen ML. The complement fixation test for bovine brucellosis. Acta Vet Scand. 1964;5:178-86.
  27. Wenger AS, Kunkel JF. A standardized method for the complement fixation test for brucellosis. Am J Vet Res. 1965;26:1103-8.
  28. Nielsen K, Kelly L, Gall D, Smith P, Bosse J, Nicoletti P, et al. International standardization of the complement fixation test for the diagnosis of bovine brucellosis. Rev Sci Tech. 1996;15(4):1345-57.
  29. Hilbink F, Wright PF. A review of the complement fixation test for brucellosis. N Z Vet J. 1988;36(1):27-31.
  30. Uzal FA, Nielsen KH, McNamara TS, Foster NJ. Comparison of ELISA with complement fixation for the diagnosis of Brucella abortus infection in cattle. J Vet Diagn Invest. 1995;7(4):452-6.
  31. Stevens MG, Olsen SC, Cheville NF. The competitive ELISA for detection of antibodies against Brucella abortus in cattle vaccinated with RB51. J Vet Diagn Invest. 1995;7(3):352-7.
  32. World Organisation for Animal Health (WOAH). Terrestrial Animal Health Code. Chapter 8.4: Infection with Brucella abortus. 2022.
  33. Bricker BJ. PCR as a diagnostic tool for brucellosis. Vet Microbiol. 2002;90(1-4):435-46.
  34. Bricker BJ, Halling SM. Differentiation of Brucella abortus bv. 1, 2, and 4, Brucella melitensis, Brucella ovis, and Brucella suis bv. 1 by PCR. J Clin Microbiol. 1994;32(11):2660-6.
  35. Cloeckaert A, Verger JM, Grayon M, Grepinet O. Restriction site polymorphism of the genes encoding the major 25 kDa and 36 kDa outer-membrane proteins of Brucella. Microbiology. 1995;141(9):2111-21.
  36. Nymo IH, Tryland M, Godfroid J, Welde B, Haug T, Mehus M, et al. Comparison of real-time PCR and bacteriological culture for detection of Brucella spp. in tissues of Arctic foxes. J Wildl Dis. 2013;49(2):364-71.
  37. Saegerman C, Peixoto I, Happe F, Berkvens D, Walravens K, Letesson JJ. Evaluation of a PCR assay for the detection of Brucella spp. in bovine placental tissues. Vet Rec. 2004;154(6):175-8.
  38. O'Leary S, Sheahan M, Sweeney T, Murphy T, Flynn O, Brennan M. Extraction of DNA from bovine feces for the detection of Brucella abortus by PCR. J Vet Diagn Invest. 2006;18(2):179-83.
  39. Probert WS, Schrader KN, Khuong NY, Bystrom SL, Graves MH. Real-time multiplex PCR assay for detection of Brucella spp., B. abortus, and B. melitensis. J Clin Microbiol. 2004;42(3):1290-3.
  40. Hinic V, Brodard I, Thomann A, Cvetnic Z, Makaya PV, Frey J, et al. Novel identification and differentiation of Brucella melitensis, B. abortus, B. suis, B. ovis, B. canis, and B. neotomae by real-time PCR targeting the bcsp31 gene. J Microbiol Methods. 2008;75(2):185-90.
  41. Baddour MM, Youssef FG, Klena JD. Evaluation of real-time PCR for the detection of Brucella spp. in clinical specimens. J Microbiol Methods. 2008;72(2):168-72.
  42. Gopaul KK, Koylass MS, Smith CJ, Whatmore AM. Rapid identification of Brucella isolates to the species level by real-time PCR based on single nucleotide polymorphisms. J Clin Microbiol. 2008;46(3):1006-11.
  43. Maringglia G, Manzulli V, Galante D, La Bella G, Serrecchia L, Petrella C, et al. Diagnostic efficiency of real-time PCR and serological tests for detection of Brucella abortus in bulk tank milk. J Dairy Sci. 2015;98(10):6840-7.
  44. Radositis OM, Gay CC, Hinchcliff KW, Constable PD. Veterinary Medicine: A Textbook of the Diseases of Cattle, Horses, Sheep, Pigs and Goats. 10th ed. Edinburgh: Saunders Elsevier; 2007.
  45. Nicoletti P. Vaccination of cattle with Brucella abortus strain 19. J Am Vet Med Assoc. 1984;184(11):1403-5.
  46. Stevens MG, Olsen SC, Cheville NF, Walker RD. Comparison of the efficacy of conjunctival and subcutaneous routes of vaccination with Brucella abortus strain RB51. Am J Vet Res. 1996;57(7):1009-13.
  47. Cheville NF, McCullough WG, Olsen SC, Stevens MG. Pathological and serological responses of cattle vaccinated with Brucella abortus strain RB51. Vet Pathol. 1993;30(4):324-32.
  48. Olsen SC, Johnson C. Comparison of the immune response of cattle vaccinated with Brucella abortus strain RB51 and strain 19. Vet Immunol Immunopathol. 1997;57(3-4):175-85.
  49. Davidson RM. Eradication of bovine brucellosis in the United States: a historical perspective. J Am Vet Med Assoc. 2003;222(9):1206-9.
  50. Radwan AI, Bekairi SI, Al-Bokmy AM, Ahmed FA, Al-Dahhashi MM, Al-Rawi AM, et al. Survival of Brucella spp. in soil and water under different environmental conditions. Rev Sci Tech. 1995;14(4):911-22.
  51. Crawford RP, Hidalgo RJ. Survival of Brucella abortus in soil and water. J Wildl Dis. 1977;13(4):397-402.
  52. Manthei CA, Carter RW. Brucellosis: survival and destruction of Brucella abortus in the environment. Adv Vet Sci. 1950;1:90-105.